Higher activity of peripheral blood angiotensin-converting enzyme is associated with later-onset of Alzheimer's disease

Journal of the Neurological Sciences

Volumn 300, Issue 1-2, 2011, Pages 67-73

  Akatsu, Hiroyasu ^a   Ogawa, Norihiro ^a   Kanesaka, Takeshi ^a   Hori, Akira ^a   Yamamoto, Takayuki ^a   Matsukawa, Noriyuki ^b   Michikawa, Makoto ^c  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Alzheimer's disease; Amyloid ; Angiotensin converting enzyme

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; DIPEPTIDYL CARBOXYPEPTIDASE;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A;

EID: 78650513585     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2010.09.030     Document Type: Article

References (47)

1. D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, and M.S. Wolfe Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 2002 535 539 (Pubitemid 34288854)
2. D.R. Borchelt, G. Thinakaran, C.B. Eckman, M.K. Lee, F. Davenport, and T. Ratovitsky Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo Neuron 17 1996 1005 1013 (Pubitemid 26424026)
3. M. Citron, D. Westaway, W. Xia, G. Carlson, T. Diehl, G. Levesque, P. St George Hyslop, and D.J. Selkoe Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice Nat Med 3 1997 67 72 (Pubitemid 27019143)
4. K. Heese, and H. Akatsu Alzheimer's disease-an interactive perspective Curr Alzheimer Res 3 2006 109 121
5. K. Zou, and M. Michikawa Angiotensin-converting enzyme as a potential target for treatment of Alzheimer's disease: inhibition or activation? Rev Neurosci 19 2008 203 212
6. E.A. Eckman, and C.B. Eckman Abeta-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention Biochem Soc Trans 33 2005 1101 1105
7. N. Iwata, S. Tsubuki, Y. Takaki, K. Shirotani, B. Lu, and N.P. Gerard Metabolic regulation of brain Abeta by neprilysin Science 292 2001 1550 1552 (Pubitemid 32493424)
8. B.C. Miller, E.A. Eckman, K. Sambamurti, N. Dobbs, K.M. Chow, and C.B. Eckman Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo Proc Nat Acad Sci USA 100 2003 6221 6226 (Pubitemid 36576957)
9. W. Farris, S. Mansourian, Y. Chang, L. Lindsley, E.A. Eckman, and M.P. Frosch Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo Proc Nat Acad Sci USA 100 2003 4162 4167 (Pubitemid 36418174)
10. S. Mueller-Steiner, Y. Zhou, H. Arai, E.D. Roberson, B. Sun, and J. Chen Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease Neuron 51 2006 703 714 (Pubitemid 44374903)
11. M.L. Hemming, and D.J. Selkoe Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor J Biol Chem 280 2005 37644 37650
12. J. Hu, A. Igarashi, M. Kamata, and H. Nakagawa Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity J Biol Chem 276 2001 47863 47868 (Pubitemid 37370682)
13. K. Zou, H. Yamaguchi, H. Akatsu, T. Sakamoto, M. Ko, and K. Mizoguchi Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition J Neurosci 27 2007 8628 8635 (Pubitemid 47254272)
14. T.C. Baghai, E.B. Binder, C. Schule, D. Salyakina, D. Eser, and S. Lucae Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism Mol Psychiatry 11 2006 1003 1015 (Pubitemid 44631643)
15. B. Rigat, C. Hubert, F. Alhenc-Gelas, F. Cambien, P. Corvol, and F. Soubrier An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels J Clin Invest 86 1990 1343 1346 (Pubitemid 20370444)
16. E. Martinez, A. Puras, J. Escribano, C. Sanchis, L. Carrion, and M. Artigao Angiotensin-converting enzyme (ACE) gene polymorphisms, serum ACE activity and blood pressure in a Spanish-Mediterranean population J Hum Hypertens 14 2000 131 135 (Pubitemid 30110447)
17. B. Keavney, C.A. McKenzie, J.M. Connell, C. Julier, P.J. Ratcliffe, and E. Sobel Measured haplotype analysis of the angiotensin-I converting enzyme gene Hum Mol Genet 7 1998 1745 1751 (Pubitemid 28464149)
18. S. Danilov, F. Savoie, B. Lenoir, X. Jeunemaitre, M. Azizi, and L. Tarnow Development of enzyme-linked immunoassays for human angiotensin I converting enzyme suitable for large-scale studies J Hypertens 14 1996 719 727 (Pubitemid 26187406)
19. L. Tiret, B. Rigat, S. Visvikis, C. Breda, P. Corvol, and F. Cambien Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels Am J Hum Genet 51 1992 197 205
20. J.V. Gainer, C.M. Stein, T. Neal, D.E. Vaughan, and N.J. Brown Interactive effect of ethnicity and ACE insertion/deletion polymorphism on vascular reactivity Hypertension 37 2001 46 51 (Pubitemid 32064238)
21. J.S. Elkins, V.C. Douglas, and S.C. Johnston Alzheimer disease risk and genetic variation in ACE: a meta-analysis Neurology 62 2004 363 368
22. D.J. Lehmann, M. Cortina-Borja, D.R. Warden, A.D. Smith, K. Sleegers, and J.A. Prince Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease Am J Epidemiol 162 2005 305 317 (Pubitemid 41389712)
23. B. Wang, F. Jin, Z. Yang, Z. Lu, R. Kan, and S. Li The insertion polymorphism in angiotensin-converting enzyme gene associated with the APOE epsilon 4 allele increases the risk of late-onset Alzheimer disease J Mol Neurosci 30 2006 267 271 (Pubitemid 46568345)
24. P.G. Kehoe, H. Katzov, L. Feuk, A.M. Bennet, B. Johansson, and B. Wiman Haplotypes extending across ACE are associated with Alzheimer's disease Hum Mol Genet 12 2003 859 867 (Pubitemid 36504028)
25. Y. Meng, C.T. Baldwin, A. Bowirrat, K. Waraska, R. Inzelberg, and R.P. Friedland Association of polymorphisms in the Angiotensin-converting enzyme gene with Alzheimer disease in an Israeli Arab community Am J Hum Genet 78 2006 871 877
26. A. Heyman, B. Peterson, G. Fillenbaum, and C. Pieper The consortium to establish a registry for Alzheimer's disease (CERAD). Part XIV: demographic and clinical predictors of survival in patients with Alzheimer's disease Neurology 46 1996 656 660 (Pubitemid 26099628)
27. M. Challah, S. Nadaud, M. Philippe, T. Battle, F. Soubrier, and B. Corman Circulating and cellular markers of endothelial dysfunction with aging in rats Am J Physiol 273 1997 H1941 H1948 (Pubitemid 127751844)
28. I.V. Yosipiv, S. Dipp, and S.S. el-Dahr Ontogeny of somatic angiotensin-converting enzyme Hypertension 23 1994 369 374 (Pubitemid 24076722)
29. A.D. Mooradian, and J. Lieberman Age-related decrease in serum angiotensin converting enzyme activity: the role of thyroidal status and food intake J Gerontol 45 1990 B24 B27 (Pubitemid 20023089)
30. O. Costerousse, J. Allegrini, H. Huang, J. Bounhik, and F. Alhenc-Gelas Regulation of ACE gene expression and plasma levels during rat postnatal development Am J Physiol 267 1994 E745 E753 (Pubitemid 2163877)
31. E. Tolosa, G. Wenning, and W. Poewe The diagnosis of Parkinson's disease Lancet Neurol 5 2006 75 86 (Pubitemid 41790698)
32. C.F. Lippa, J.E. Duda, M. Grossman, H.I. Hurtig, D. Aarsland, and B.F. Boeve DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers Neurology 68 2007 812 819 (Pubitemid 46568532)
33. G.M. McKhann, M.S. Albert, M. Grossman, B. Miller, D. Dickson, and J.Q. Trojanowski Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease Arch Neurol 58 2001 1803 1809 (Pubitemid 33044246)
34. U. Nath, Y. Ben-Shlomo, R.G. Thomson, A.J. Lees, and D.J. Burn Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study Neurology 60 2003 910 916 (Pubitemid 36348920)
35. M. Doran, D.G. du Plessis, T.P. Enevoldson, N.A. Fletcher, E. Ghadiali, and A.J. Larner Pathological heterogeneity of clinically diagnosed corticobasal degeneration J Neurol Sci 216 2003 127 134 (Pubitemid 37371877)
36. M. Yamada Senile dementia of the neurofibrillary tangle type (tangle-only dementia): neuropathological criteria and clinical guidelines for diagnosis Neuropathology 23 2003 311 317 (Pubitemid 38004865)
37. P.L. Hurst, and C.J. Lovell-Smith Optimized assay for serum angiotensin-converting enzyme activity Clin Chem 27 1981 2048 2052 (Pubitemid 12194441)
38. H.M. Neels, S.L. Scharpe, M.E. van Sande, R.M. Verkerk, and K.J. Van Acker Improved micromethod for assay of serum angiotensin converting enzyme Clin Chem 28 1982 1352 1355 (Pubitemid 12125073)
39. H. Biller, G. Zissel, B. Ruprecht, M. Nauck, A. Busse Grawitz, and J. Muller-Quernheim Genotype-corrected reference values for serum angiotensin-converting enzyme Eur Respir J 28 2006 1085 1090 (Pubitemid 44883841)
40. F. Soubrier, S. Martin, A. Alonso, S. Visvikis, L. Tiret, and F. Matsuda High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity Eur J Hum Genet 10 2002 553 561 (Pubitemid 35012310)
41. H. Akatsu, M. Takahashi, N. Matsukawa, Y. Ishikawa, N. Kondo, and T. Sato Subtype analysis of neuropathologically diagnosed patients in a Japanese geriatric hospital J Neurol Sci 196 2002 63 69 (Pubitemid 34311542)
42. N. Pomara, B. Shao, T. Wisniewski, and P.D. Mehta Decreases in plasma A beta 1-40 levels with aging in non-demented elderly with ApoE-epsilon 4 allele Neurochem Res 23 1998 1563 1566 (Pubitemid 28516297)
43. E. Savaskan, C. Hock, G. Olivieri, S. Bruttel, C. Rosenberg, and C. Hulette Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia Neurobiol Aging 22 2001 541 546 (Pubitemid 32607737)
44. N.M. Barnes, C.H. Cheng, B. Costall, R.J. Naylor, T.J. Williams, and C.M. Wischik Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease Eur J Pharmacol 200 1991 289 292
45. J.S. Miners, E. Ashby, Z. Van Helmond, K.A. Chalmers, L.E. Palmer, and S. Love Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy Neuropathol Appl Neurobiol 34 2008 181 193 (Pubitemid 351327960)
46. H.M. Nielsen, E. Londos, L. Minthon, and S.M. Janciauskiene Soluble adhesion molecules and angiotensin-converting enzyme in dementia Neurobiol Dis 26 2007 27 35 (Pubitemid 46436485)
47. G.S. Zubenko, L. Volicer, L.K. Direnfeld, M. Freeman, P.J. Langlais, and R.A. Nixon Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy Brain Res 328 1985 215 221 (Pubitemid 15135146)